- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Glabellar Crease
Total 10000 results
-
Fudan UniversityNot yet recruitingTNBC - Triple-Negative Breast Cancer
-
National Taiwan University HospitalRecruitingBreast Cancer | Hormone Receptor-positive Breast Cancer | Hormone TherapyTaiwan
-
Fudan UniversityGeneQuantum Healthcare (Suzhou) Co., Ltd.RecruitingAdvanced/ Metastatic Her-2 Positive Breast CancerChina
-
Seoul National University HospitalRecruitingAdvanced Breast CancerSouth Korea
-
Henan Cancer HospitalRecruitingHR Positive HER2 Negative Advanced Breast CancerChina
-
Fudan UniversityRecruiting
-
Tianjin Medical University Cancer Institute and...Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityNot yet recruitingHER2+ Early or Locally Advanced Breast Cancer
-
Centre Paul StraussRecruiting
-
University of RochesterRecruitingBreast Cancer Female | Cancer Related Cognitive DifficultiesUnited States
-
Centre Antoine LacassagneWithdrawnHER2 Negative Breast Cancer Not Immediately OperatedFrance
-
PfizerArvinas Estrogen Receptor, Inc.Active, not recruitingAdvanced Breast CancerUnited States, Spain, China, Canada, Australia, Taiwan, Japan, India, Slovakia, Belgium, Argentina, Brazil, South Africa, United Kingdom, Puerto Rico, Austria, Finland, Greece, Italy, Bulgaria, Germany, Hungary, Czechia, France, Sweden, M... and more
-
M.D. Anderson Cancer CenterActive, not recruitingAnatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Early Stage Triple-Negative Breast Carcinoma | Early Stage HER2-Positive Breast CarcinomaUnited States
-
Carol Fabian, MDCompletedIncreased Risk for Development of Breast CancerUnited States
-
Centre Jean PerrinInternational Cancer Research Group, United Arab EmiratesActive, not recruitingBRCA1 Mutation | BRCA2 Mutation | Breast Cancer FemaleFrance
-
Istanbul Sabahattin Zaim UniversityCompletedPsychological Resilience | Posttraumatic Growth | Breast Cancer PatientsTurkey
-
National University Hospital, SingaporeAdagene IncActive, not recruitingAdvanced Solid Tumor | HER2-negative Breast CancerSingapore
-
Xuanzhu Biopharmaceutical Co., Ltd.Active, not recruitingAdvanced Breast CancerChina
-
Boston Medical CenterBreast Cancer AllianceWithdrawn
-
University of CoimbraPortuguese National Funding Agency for Science, Research and Technology (FCT)Active, not recruiting
-
Jules Bordet InstituteRoche Pharma AGCompletedHER-2 Positive Breast CancerBelgium, Netherlands
-
AbbVieCompletedMetastatic Breast CancerUnited States, Argentina, Australia, Austria, Belarus, Belgium, Canada, Chile, Colombia, Czechia, Denmark, Estonia, Finland, France, Germany, Hungary, Israel, Italy, Korea, Republic of, Latvia, Lithuania, Mexico, Netherlands, Norway, Po... and more
-
Fox Chase Cancer CenterAmerican Cancer Society, Inc.Active, not recruiting
-
Memorial Sloan Kettering Cancer CenterNovartis PharmaceuticalsCompletedMetastatic or Locally-advanced Unresectable Breast CancerUnited States
-
Fondazione Policlinico Universitario Agostino Gemelli...Completed
-
Massachusetts General HospitalNational Comprehensive Cancer NetworkCompleted
-
The Second Hospital of Anhui Medical UniversityCompleted
-
Zheng YabingEnrolling by invitation
-
Abramson Cancer Center at Penn MedicineCompletedEstrogen-receptor Positive Invasive Metastatic Breast CancerUnited States
-
Xuanzhu Biopharmaceutical Co., Ltd.Active, not recruitingAdvanced Breast CancerChina
-
University of WashingtonNational Cancer Institute (NCI)CompletedBreast Cancer | Invasive Breast CarcinomaUnited States
-
Hoffmann-La RocheCompletedHER2-Positive Early Breast CancerUnited States, Finland, Hong Kong, Panama, Portugal, Spain, Mexico, Sweden, Brazil, Serbia, Argentina, Lebanon, Cuba, Qatar, Saudi Arabia, Chile, Jordan
-
Jiangsu HengRui Medicine Co., Ltd.Completed
-
Veru Inc.WithdrawnMetastatic Breast CancerUnited States
-
PfizerCompletedHR+/HER2- Locally Advanced, Metastatic Breast CancerUnited Kingdom
-
MedSIRTerminatedAdvanced Breast CancerSpain
-
West China HospitalCompleted
-
National Cancer Center, KoreaCompletedBreast Cancer SurvivorsKorea, Republic of
-
SCRI Development Innovations, LLCMillennium Pharmaceuticals, Inc.CompletedMetastatic Breast CancerUnited States
-
Medipol UniversityCompletedBreast Cancer | Breast Neoplasms | Breast Cancer FemaleTurkey
-
Eli Lilly and CompanyTerminatedMetastatic Breast CancerUnited States, Puerto Rico
-
MVG Industries SASHRB Clinical Research Facility, Galway (CRFG)CompletedBreast Cancer | Breast CystIreland
-
Jiangsu HengRui Medicine Co., Ltd.Unknown
-
University of LeedsBreast Cancer NowCompletedMetastatic Breast CancerUnited Kingdom
-
GTxCompletedER+ and AR+ Breast CancerUnited States
-
OncoMed Pharmaceuticals, Inc.CompletedMetastatic Breast CancerUnited States
-
Chang Gung Memorial HospitalCompleted
-
Central European Cooperative Oncology GroupCompletedMetastatic Breast CancerSerbia, Israel, Croatia, Hungary, Poland, Bosnia and Herzegovina, Latvia, Slovakia, Austria, Czechia, Bulgaria, Romania
-
Novartis PharmaceuticalsBreast International Group; German Breast Group; SOLTI Breast Cancer Research...CompletedHER2-positive Newly Diagnosed, Primary Breast CancerAustria, Spain, Australia, Germany
-
Eli Lilly and CompanyCompleted
-
Pierre Fabre MedicamentTerminated